Brush‐on‐Brush Architecture Enables Durable and Reversible Aptamer Therapeutics With Minimal PEG Associated Immunogenicity

Journal:
Advanced Materials
Published:
DOI:
10.1002/adma.73308
Affiliations:
2
Authors:
9
Go to article
Institutions Authors Share
Hangzhou Institute of Medicine (HIM), CAS, China
7.000000
 0.78
Stomatology Hospital, AHMU, China
2.000000
 0.22
Interested in Pharmacology and Pharmaceutical Sciences?